Product Information

ESCITALOPRAM 5 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0429 per EA under NDC 68001059100. Its NADAC has been published 144 times since Feb 14, 2024.

FDA first approved this application on Aug 28, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ESCITALOPRAM 5 MG TABLET

Escitalopram
$0.0429per EA

Strength

5 mg/1

NDC

68001059100

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ESCITALOPRAM OXALATE

Approval Type

Generic (ANDA)

FDA Application

ANDA078032

FDA Approved

8/28/2015

TE Code

AB

On Market Since

12/18/2023

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for ESCITALOPRAM 5 MG TABLET has been published 144 times since Feb 14, 2024, and over the history we have for it it has declined 14.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0429 per EA
All-time high$0.0501 (Apr 10, 2024)
All-time low$0.0328 (Nov 20, 2024)
52-week high$0.0429
52-week low$0.0412
Median price$0.0423
Average price$0.0428
Largest weekly change-27.3% (Nov 20, 2024)
Weeks tracked144
Tracking sinceFeb 14, 2024

Price History

1W

0.0%

1M

+3.1%

3M

+1.3%

6M

+3.9%

1Y

+1.9%

3Y

N/A

5Y

N/A

All

-14.2%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ESCITALOPRAM 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by BluePoint Laboratories, is $0.0429 per EA (NDC 68001059100), effective Nov 11, 2026.

How has the price of ESCITALOPRAM 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 14.2%. It has been tracked across 144 weekly CMS publications since Feb 14, 2024.

What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?

Since Feb 14, 2024, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.0501 (Apr 10, 2024), with a median of $0.0423 per EA.

Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESCITALOPRAM 5 MG TABLET, is $0.0419 per EA — about 2% below ESCITALOPRAM 5 MG TABLET.

Who manufactures ESCITALOPRAM 5 MG TABLET?

ESCITALOPRAM 5 MG TABLET (NDC 68001059100) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.